Rockwell Medical (RMTI) Income towards Parent Company (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Income towards Parent Company came in at -$7.2 million in Q1 2026, down 290.63% YoY from $3.8 million in Q1 2025, and down 336.77% on a QoQ basis from -$1.7 million in Q4 2025.
Rockwell Medical (RMTI) Income towards Parent Company (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Income towards Parent Company data on file, last reported at -$7.2 million in Q1 2026.
- Quarterly Income towards Parent Company fell 290.63% year-over-year to -$7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13.5 million (down 2145.27% YoY) and the FY2025 annual result came in at -$11.4 million, up 86.57% from the prior year.
- Income towards Parent Company fell to -$7.2 million in Q1 2026, from -$1.7 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $1.5 million in Q3 2024 to a low of -$7.2 million in Q1 2026.
- A 5-year average of -$2.5 million and a median of -$1.9 million in 2022 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2024 — Income towards Parent Company jumped 170.82% — and 2025, when it plunged 2748.98%.
- Tracing RMTI's Income towards Parent Company over 5 years: stood at -$1.9 million in 2022, then gained by 14.93% to -$1.6 million in 2023, then soared by 76.94% to -$372000.0 in 2024, then plunged by 343.82% to -$1.7 million in 2025, then tumbled by 336.77% to -$7.2 million in 2026.
- The last three Income towards Parent Company figures came in at -$7.2 million (Q1 2026), -$1.7 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Rockwell Medical | 29.77 Mn | 4.98 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.32 Mn |
| Mar 31, 2026 | -7.21 Mn |
| Dec 31, 2025 | -1.65 Mn |
| Sep 30, 2025 | -2.08 Mn |
| Jun 30, 2025 | -2.60 Mn |
| Mar 31, 2025 | -1.85 Mn |
| Dec 31, 2024 | -372,000.00 |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 98,000.00 |
| Mar 31, 2024 | -1.74 Mn |
| Dec 31, 2023 | -1.61 Mn |
| Sep 30, 2023 | -2.14 Mn |
| Jun 30, 2023 | -3.39 Mn |
| Mar 31, 2023 | -1.79 Mn |
| Dec 31, 2022 | -1.90 Mn |
| Sep 30, 2022 | -4.19 Mn |
| Jun 30, 2022 | -4.97 Mn |
| Mar 31, 2022 | -7.17 Mn |
| Dec 31, 2021 | -8.41 Mn |
| Sep 30, 2021 | -7.58 Mn |